Dr Lada Leyens has a background in human genetics health economics and personalized medicine. She has worked at Health Authorities for over 8 years mainly as a clinical trial assessor and GCP inspector at Swissmedic. At EMA she was in the specialized disciplines office working in the centralized procedure on clinical pharmacology and pharmacogenomics aspects. Lada is associated with MAHE as Endowed Chair and Coordinator for the Center for Regulatory Science PSPH wit the priority to advice regulatory science research. She is coordinating an executive course on drug development and regulatory science in partnership with European Centre for Regulatory Science Basel University. Lada also works at Roche since 2019 as Senior Regulatory Director focusing on clinical trial innovation and digital health.